Cargando…
Effect of Acute Immunosuppression on Left Ventricular Recovery and Mortality in Fulminant Viral Myocarditis: A Case Series and Review of Literature
BACKGROUND: Fulminant viral myocarditis (FVM) is a rare cause of cardiogenic shock associated with high morbidity and mortality rates. An inappropriately activated immune system results in severe myocardial inflammation. Acute immunosuppressive therapy for FVM therefore gained in popularity and was...
Autores principales: | Turgeon, Pierre Yves, Massot, Montse, Beaupré, Frédéric, Belzile, David, Beaudoin, Jonathan, Bernier, Mathieu, Bourgault, Christine, Germain, Valérie, Laliberté, Claudine, Morin, Joëlle, Gervais, Philippe, Trahan, Sylvain, Charbonneau, Éric, Dagenais, François, Sénéchal, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985012/ https://www.ncbi.nlm.nih.gov/pubmed/33778446 http://dx.doi.org/10.1016/j.cjco.2020.10.017 |
Ejemplares similares
-
Ten Questions Cardiologists Should Be Able to Answer About Cardiac Sarcoidosis: Case-Based Approach and Contemporary Review
por: Lemay, Sylvain, et al.
Publicado: (2020) -
Successive immunosuppressive treatment of fulminant myocarditis that is refractory to mechanical circulatory support
por: Nakashima, Hiroshi, et al.
Publicado: (2013) -
Immunosuppressive treatment in fulminant myocarditis and gene expression pattern associated with, but no histological confirmation of giant cell myocarditis
por: Fruhwald, Friedrich, et al.
Publicado: (2017) -
Early characteristics of fulminant myocarditis vs non-fulminant myocarditis: A meta-analysis
por: Wang, Zicheng, et al.
Publicado: (2019) -
Fulminant myocarditis in the time of coronavirus
por: Cuomo, Vittoria, et al.
Publicado: (2020)